OCT 1, 2026 · JOURNAL ARTICLE
Concordance of tumor-informed and tumor-agnostic ctDNA assays for treatment response monitoring in advanced solid tumors
The Journal of Liquid Biopsy
Circulating tumor DNA (ctDNA), obtained serially during cancer treatment, can capture tumor burden trends to help interpret response and detect resistance to systemic therapy for p